✉news HealthMedicine first seen 13 h ago, last 45 min ago, peak #6

Laverock Therapeutics Expands Into In Vivo CAR-T and Genetic Medicine

Original: Cell Therapy Weekly: Laverock Therapeutics Expands to In Vivo CAR-T and Genetic Medicine

Biotech company Laverock Therapeutics has announced an expansion of its work into in vivo CAR-T cell therapy and broader genetic medicine. The move, covered in RegMedNet's Cell Therapy Weekly roundup, signals the company's ambition to move beyond ex vivo approaches and develop therapies delivered directly inside the body. Observers in the regenerative medicine field are watching how the strategy develops.

Why now: The announcement was featured in a regenerative medicine news roundup, drawing attention from cell therapy industry watchers.

Laverock TherapeuticsRegMedNet

Open on news →

Rank over time, top of the chart is #1. 4 snapshots from 4 h ago to 45 min ago.

Evidence

• Cell Therapy Weekly: Laverock Therapeutics Expands to In Vivo CAR-T and Genetic Medicine · RegMedNet

API: https://socialmediatrends-api.osmike.com/v1/trends/672590